{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:43:37Z","timestamp":1784367817688,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.humimm.2025.111610","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:05:26Z","timestamp":1762614326000},"page":"111610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["NLRP3 genetic variants and their impact on psoriasis susceptibility, severity, and risk of psoriatic arthritis"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8781-1505","authenticated-orcid":false,"given":"C\u00e1ssio Rafael","family":"Moreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Cataldi","family":"de Alc\u00e2ntara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia Marcia","family":"Mario Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcell Alysson","family":"Batisti Lozovoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a Name","family":"Colado Sim\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna Maria","family":"Vissoci Reiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10281","key":"10.1016\/j.humimm.2025.111610_b0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"Griffiths","year":"2021","journal-title":"Psoriasis. Lancet."},{"issue":"2","key":"10.1016\/j.humimm.2025.111610_b0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"9997","key":"10.1016\/j.humimm.2025.111610_b0015","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"Boehncke","year":"2015","journal-title":"Psoriasis. Lancet."},{"issue":"5","key":"10.1016\/j.humimm.2025.111610_b0020","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.3390\/ijms24054901","article-title":"Psoriatic Arthritis: Pathogenesis and Targeted Therapies","volume":"24","author":"Azuaga","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.humimm.2025.111610_b0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/09546634.2019.1605142","article-title":"Psoriatic arthritis for dermatologists","volume":"31","author":"Gottlieb","year":"2020","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.humimm.2025.111610_b0030","article-title":"Psoriasis and Co-morbidity","volume":"100(3):adv00033","author":"Amin","year":"2020","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"10.1016\/j.humimm.2025.111610_b0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molimm.2014.12.014","article-title":"Genetic and epigenetic basis of psoriasis pathogenesis","volume":"64","author":"Chandra","year":"2015","journal-title":"Molecular Immunol."},{"key":"10.1016\/j.humimm.2025.111610_b0040","doi-asserted-by":"crossref","unstructured":"Munir S, ber Rahman S, Rehman S, Saba N, Ahmad W, Nilsson S, et al. Association analysis of GWAS and candidate gene loci in a Pakistani population with psoriasis.Molecular Immunol. 2015; 64(1), 190-194.","DOI":"10.1016\/j.molimm.2014.11.015"},{"issue":"23","key":"10.1016\/j.humimm.2025.111610_b0045","doi-asserted-by":"crossref","first-page":"13554","DOI":"10.1111\/jcmm.15742","article-title":"Overview of the molecular determinants contributing to the expression of Psoriasis and Psoriatic Arthritis phenotypes","volume":"24","author":"Caputo","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"17","key":"10.1016\/j.humimm.2025.111610_b0050","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.3390\/ijms22179294","article-title":"The Role of Epigenetic Factors in Psoriasis","volume":"22","author":"Dopytalska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2025.111610_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2017.07.007","article-title":"Psoriasis: a mixed autoimmune and autoinflammatory disease","volume":"49","author":"Liang","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"23","key":"10.1016\/j.humimm.2025.111610_b0060","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1242\/jcs.207365","article-title":"Inflammasome activation and assembly at a glance","volume":"130","author":"Malik","year":"2017","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.humimm.2025.111610_b0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2023.06.007","article-title":"Potential roles of inflammasomes in the pathophysiology of Psoriasis: a comprehensive review","volume":"161","author":"Shahi","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2025.111610_b0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","article-title":"NLRP3 Inflammasome and Inflammatory Bowel Disease","volume":"10","author":"Zhen","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2025.111610_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110542","article-title":"Role of the NLRP3 inflammasome in autoimmune diseases","volume":"130","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.humimm.2025.111610_b0080","doi-asserted-by":"crossref","unstructured":"Yin H, Liu N, Sigdel KR, Duan L. Role of NLRP3 Inflammasome in Rheumatoid Arthritis. Front Immunol. 2022 Jun 27;13:931690. doi: 10.3389\/fimmu.2022.931690. Erratum in: Front Immunol. 2023; 14:1228176. doi: 10.3389\/fimmu.2023.1228176.","DOI":"10.3389\/fimmu.2022.931690"},{"key":"10.1016\/j.humimm.2025.111610_b0085","doi-asserted-by":"crossref","unstructured":"S\u00e1 DC, Festa C Neto. Inflammasomes and dermatology. An Bras Dermatol. 2016; 91(5):566-578. doi: 10.1590\/abd1806-4841.20165577.","DOI":"10.1590\/abd1806-4841.20165577"},{"key":"10.1016\/j.humimm.2025.111610_b0090","doi-asserted-by":"crossref","first-page":"15382","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Tsoi","year":"2017","journal-title":"Nat. Commun."},{"issue":"10\u201312","key":"10.1016\/j.humimm.2025.111610_b0095","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00011-021-01514-6","article-title":"Association between IL-17A, IL-17F and IL-17RA gene polymorphisms and susceptibility to psoriasis and psoriatic arthritis: a meta-analysis","volume":"70","author":"Villalpando-Vargas","year":"2021","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.humimm.2025.111610_b0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12881-018-0742-2","article-title":"Polymorphisms in IL36G gene are associated with plaque psoriasis","volume":"20","author":"Traks","year":"2019","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.humimm.2025.111610_b0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2023.05.010","article-title":"IL36G genetic variant is independently associated with susceptibility, severity and joint involvement in psoriasis","volume":"159","author":"Moreira","year":"2023","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2025.111610_b0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jdermsci.2014.05.010","article-title":"Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus","volume":"75","author":"Eir\u00eds","year":"2014","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.humimm.2025.111610_b0115","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/jocd.14940","article-title":"TNF-\u03b1 gene -238G>A polymorphism is associated with psoriasis patients","volume":"21","author":"Akc\u0131lar","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"3","key":"10.1016\/j.humimm.2025.111610_b0120","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jid.2020.07.012","article-title":"Enhanced Inflammasome activity in patients with Psoriasis Promotes Systemic Inflammation","volume":"141","author":"Verma","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.humimm.2025.111610_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4714836","article-title":"Association ofNLRP1andNLRP3Polymorphisms with Psoriasis Vulgaris Risk in the Chinese Han Population","volume":"2018","author":"Yu","year":"2018","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.humimm.2025.111610_b0130","article-title":"NLRP3-inflammasome Related Genes as Emerging Biomarkers and Therapeutic Targets in Psoriasis","volume":"3","author":"Shi","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.humimm.2025.111610_b0135","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/TACG.S319065","article-title":"Evaluation of NLRP3 (rs10754558) and PTPN22 (1858C\/T) (rs2476601) Functional Polymorphisms in Psoriasis Susceptibility in Egypt","volume":"14","author":"Alrefai","year":"2021","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.humimm.2025.111610_b0140","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The International HapMap Project","volume":"426","author":"The International HapMap Consortium","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.humimm.2025.111610_b0145","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/jomb-2016-0008","article-title":"NLRP3andCARD8Polymorphisms Influence Higher disease activity in Rheumatoid Arthritis","volume":"5","author":"Jenko","year":"2016","journal-title":"J Med Biochem."},{"key":"10.1016\/j.humimm.2025.111610_b0150","article-title":"Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma","volume":"124(4):779-85.e6","author":"Hitomi","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2025.111610_b0155","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/09612033211014273","article-title":"Three functional variants in the NLRP3 gene are associated with susceptibility and clinical characteristics of systemic lupus erythematosus","volume":"30","author":"Ehtesham","year":"2021","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.humimm.2025.111610_b0160","first-page":"260","article-title":"A susceptibility putative haplotype within NLRP3 inflammasome gene influences ischaemic stroke risk in the population of Punjab","volume":"49","author":"Kumar","year":"2022","journal-title":"India. Int J Immunogenetics."},{"issue":"3","key":"10.1016\/j.humimm.2025.111610_b0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.55133\/eji.300311","article-title":"NLRP3 inflammasome (rs10754558) gene polymorphism in patients with atopic dermatitis","volume":"30","author":"El Gendy","year":"2023","journal-title":"Egypt. J. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2025.111610_b0170","doi-asserted-by":"crossref","first-page":"745","DOI":"10.15537\/smj.2023.44.8.20230322","article-title":"The NLRP3 inflammasome rs35829419 C>A polymorphism is associated with type 2 diabetes mellitus in Saudi Arabia","volume":"44","author":"Kaabi","year":"2023","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.humimm.2025.111610_b0175","article-title":"Association betweenNLRP3 rs10754558andCARD8 rs2043211Variants and Susceptibility to Chronic Kidney Disease","volume":"24(4):4184","author":"La Russa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.humimm.2025.111610_b0180","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1038\/s41598-020-63469-8","article-title":"Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma","volume":"10","author":"Chung","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2025.111610_b0185","doi-asserted-by":"crossref","unstructured":"Hsueh YM, Chen WJ, Lin YC, Huang YL, Shiue HS, Lin YF, Hsieh RL, Chen HH. Combined effects of nucleotide-binding domain-like receptor protein 3 polymorphisms and environmental metals exposure on chronic kidney disease. Sci Rep. 2022; 12(1):6307. doi: 10.1038\/s41598-022-10098-y. Erratum in: Sci Rep. 2022; 12(1):22600. doi: 10.1038\/s41598-022-27056-3.","DOI":"10.1038\/s41598-022-27056-3"},{"issue":"4","key":"10.1016\/j.humimm.2025.111610_b0190","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/s41380-021-01431-4","article-title":"In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach","volume":"27","author":"Maes","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.humimm.2025.111610_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192010","article-title":"Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis","volume":"13","author":"Loft","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.humimm.2025.111610_b0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12865-024-00630-2","article-title":"NLRP3 (rs10754558) gene polymorphism and tumor necrosis factor alpha as predictors for disease activity and response to methotrexate and adalimumab in psoriasis","volume":"25","author":"Kamel","year":"2024","journal-title":"BMC Immunol."},{"key":"10.1016\/j.humimm.2025.111610_b0205","doi-asserted-by":"crossref","unstructured":"Farag A, Badr E, Elnaidany N, Gaafar N, Elmadbouh I. Association of NLRP1 (rs878329) and NLRP3 (rs10754558) genes polymorphism in psoriasis vulgaris patients with dyslipidemia. Hum Gene. 2022; 33:201052. https:\/\/doi. org\/10.1016\/j.humgen.2022.201052.","DOI":"10.1016\/j.humgen.2022.201052"},{"issue":"5","key":"10.1016\/j.humimm.2025.111610_b0210","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2005.06502.x","article-title":"Current severe psoriasis and the rule of tens","volume":"152","author":"Finlay","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.humimm.2025.111610_b0215","doi-asserted-by":"crossref","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic Arthritis. N Engl J Med. 2017 Mar 9;376(10):957-970. doi: 10.1056\/NEJMra1505557. Erratum in: N Engl J Med. 2017; 25;376(21):2097. doi: 10.1056\/NEJMx170005.","DOI":"10.1056\/NEJMra1505557"},{"issue":"2","key":"10.1016\/j.humimm.2025.111610_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017063","article-title":"The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected","volume":"6","author":"Pena","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2025.111610_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mgene.2015.04.003","article-title":"Genetic model selection for a case-control study and a meta-analysis","volume":"5","author":"Horita","year":"2015","journal-title":"Meta Gene."},{"issue":"15","key":"10.1016\/j.humimm.2025.111610_b0230","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: a web tool for the analysis of association studies","volume":"22","author":"Sol\u00e9","year":"2006","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.humimm.2025.111610_b0235","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/mgme.2000.3015","article-title":"Molecular heterosis: a review","volume":"71","author":"Comings","year":"2000","journal-title":"Mol. Genet. Metab."},{"issue":"40","key":"10.1016\/j.humimm.2025.111610_b0240","doi-asserted-by":"crossref","first-page":"9657","DOI":"10.1523\/JNEUROSCI.0991-17.2017","article-title":"Overdominant effect of aCHRNA4Polymorphism on Cingulo-Opercular network activity and Cognitive Control","volume":"37","author":"Sadaghiani","year":"2017","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.humimm.2025.111610_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16814","article-title":"Effect of NLRP3 inflammasome genes polymorphism on disease susceptibility and response to TNF-\u03b1 inhibitors in Iraqi patients with rheumatoid arthritis","volume":"9","author":"Awni","year":"2023","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.humimm.2025.111610_b0250","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3892\/etm.2021.10544","article-title":"NLRP3 gene polymorphisms and expression in rheumatoid arthritis","volume":"22","author":"Cheng","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.humimm.2025.111610_b0255","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1389202923666220527111037","article-title":"Etiopathogenesis of Psoriasis from Genetic Perspective: an updated Review","volume":"23","author":"Babaie","year":"2022","journal-title":"Curr. Genomics"},{"issue":"1","key":"10.1016\/j.humimm.2025.111610_b0260","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A critical Role of the IL-1\u03b2-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.humimm.2025.111610_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1321370","article-title":"Genetic variations in NLRP3 and NLRP12 genes in adult-onset patients with autoinflammatory diseases: a comparative study","volume":"14","author":"Yun","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111610_b0270","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13075-021-02545-4","article-title":"Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review","volume":"23","author":"Mulder","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.humimm.2025.111610_b0275","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2340\/00015555-0642","article-title":"Epidemiological study of psoriasis in the national health insurance database in Taiwan","volume":"89","author":"Chang","year":"2009","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.humimm.2025.111610_b0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaad.2004.07.045","article-title":"The prevalence of psoriasis in African Americans: results from a population-based study","volume":"52","author":"Gelfand","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.humimm.2025.111610_b0285","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/jcm13020492","article-title":"Multimorbidity of Psoriasis: a Large-Scale Population Study of its Associated Comorbidities","volume":"13","author":"Almenara-Blasco","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.humimm.2025.111610_b0290","doi-asserted-by":"crossref","first-page":"A615","DOI":"10.1016\/S1098-3015(10)67013-1","article-title":"PSS21 Administrative Prevalence of Psoriasis in Germany","volume":"11","author":"Schlander","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.humimm.2025.111610_b0295","article-title":"Patterns of Comorbidities in Psoriasis patients: a Cross-Sectional Study","volume":"13","author":"Alajmi","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.humimm.2025.111610_b0300","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/jhs.JHS_136_16","article-title":"Proportions of major comorbid medical conditions among psoriasis patients in a tertiary hospital","volume":"5","author":"Hassan","year":"2017","journal-title":"Riyadh. J Health Spec."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925003817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925003817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:47:29Z","timestamp":1768402049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885925003817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0198885925003817"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111610","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 genetic variants and their impact on psoriasis susceptibility, severity, and risk of psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111610"}}